These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 32221022)
1. Effectiveness of CO Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022 [TBL] [Abstract][Full Text] [Related]
2. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595 [TBL] [Abstract][Full Text] [Related]
3. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261 [TBL] [Abstract][Full Text] [Related]
4. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500 [TBL] [Abstract][Full Text] [Related]
6. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy. Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104 [TBL] [Abstract][Full Text] [Related]
7. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832 [TBL] [Abstract][Full Text] [Related]
8. CO Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713 [TBL] [Abstract][Full Text] [Related]
9. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986 [TBL] [Abstract][Full Text] [Related]
10. [Short-term efficacy of vaginal CO Kozma B; Póka R; Sipos A; Ács N; Takács P Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579 [TBL] [Abstract][Full Text] [Related]
11. The Fractional CO Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334 [TBL] [Abstract][Full Text] [Related]
12. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Sokol ER; Karram MM Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
14. [How I do? a treatment with fractional CO Jardin I; Louis-Vahdat C; Canlorbe G; Mergui JL; Uzan C; Azaïs H Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):735-739. PubMed ID: 30266539 [No Abstract] [Full Text] [Related]
15. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause. Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422 [TBL] [Abstract][Full Text] [Related]
16. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052 [TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047 [TBL] [Abstract][Full Text] [Related]
18. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486 [TBL] [Abstract][Full Text] [Related]
19. Vaginal CO Pearson A; Booker A; Tio M; Marx G Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895 [TBL] [Abstract][Full Text] [Related]